News
The company will use the funds to move into the female health space and increase screening and preventive care.
The funds will be used to increase the development of GAIA-based Alzheimer's disease drugs and widen the pipeline of blockbuster drug candidates.
The news comes alongside the U.S. Department of Defense’s announcement of $200 million contracts awarded to xAI, Anthropic, Google and OpenAI for AI implementation.
AI and synthetic-driven research can help clinicians gain a patient's trust, according to Adrienne Boissy, Qualtrics CMO.
The funds will be used to improve the company's flight cadence and expand its pharmaceutical lab capabilities.
The AI co-developed with ASX-listed Artrya can outperform the Agatston score in predicting cardiac events.
It can also predict the onset of Parkinson's motor symptoms.
Developing an AI platform internally can be more cost-effective and manageable, said Ryan Sadeghian, chief medical information officer at the University of Toledo, at HIMSS AI Forum.
Plaintiffs allege that CRISP and its subsidiary willfully infringed on patented technology by launching a copycat product after terminating a long-standing licensing agreement.
Also, four tuberculosis screening AI solutions from Asia-Pacific are among those recommended by the World Health Organization.